Acute Stimulation and Modulation of Stereotyped High-Frequency Oscillations

ConditionEpilepsy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-70
SponsorMayo Clinic

About this trial

Overall, this study will investigate the functional utility of stereotyped HFOs by capturing them with a new implantable system (Brain Interchange - BIC of CorTec), which can sample neural data at higher rates \>=1kHz and deliver targeted electrical stimulation to achieve seizure control. In contrast to current closed-loop systems (RNS), which wait for the seizure to start before delivering stimulation, the BIC system will monitor the spatial topography and rate of stereotyped HFOs and deliver targeted stimulation to these HFO generating areas to prevent seizures from occurring. If the outcomes of our research in an acute setting become successful, the investigators will execute a clinical trial and run the developed methods with the implantable BIC system in a chronic ambulatory setting.

Eligibility criteria

Qualifiers

Patients with medically refractory epilepsy, who have been deemed appropriate candidates for intracranial EEG monitoring

Adult men and women (18≤ age <70 years)

Children (3≤ age <18 years)

Includes women and minorities

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Brain Interchange System

Treatment groups

8 Participants
are divided into 1 treatment group

Sponsors and collaborators

Mayo Clinic

Lead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

Baylor College of Medicine

Collaborator

CorTec GmbH

Collaborator